8-K: SurgePays Warrants Expire, No Outstanding Warrants Remain
Current Report
SurgePays, Inc. reports the expiration of its Common Stock Purchase Warrants on November 4, 2024, with no outstanding warrants remaining.
Summary
- SurgePays, Inc. has announced the expiration of its Common Stock Purchase Warrants.
- The warrants, previously traded on the Nasdaq under the symbol SURGW, expired on November 4, 2024.
- These warrants were issued as part of an underwriting agreement with Maxim Group LLC dated November 1, 2021.
- The warrants had an initial exercise price of $4.73 per share.
- The warrants expired three years from the date of issuance.
- As of November 4, 2024, no warrants are outstanding or can be exercised.
Sentiment
Score: 6
Explanation: The document reports a neutral event, the expected expiration of warrants. It is neither positive nor negative for the company's operations.
Positives
- The expiration of the warrants removes potential dilution from the market.
Management Comments
- Kevin Brian Cox, Chief Executive Officer, signed the report on behalf of SurgePays, Inc.
Industry Context
The expiration of warrants is a common event in the life cycle of publicly traded companies, particularly those that have raised capital through the issuance of warrants. This event is specific to SurgePays and does not indicate a broader trend in the industry.
Comparison to Industry Standards
- The expiration of warrants is a standard process for companies that have issued them as part of financing activities.
- Many companies, such as those in the technology and growth sectors, use warrants as a way to attract investors.
- The terms of the warrants, including the exercise price and expiration date, are typically outlined in the underwriting agreement and are specific to each company.
Stakeholder Impact
- The expiration of the warrants may have a minor impact on shareholders as it removes potential dilution.
Key Dates
| Date | Description |
|---|---|
| 2019-09-12 | Initial filing of the registration statement on Form S-1 with the Securities and Exchange Commission. |
| 2021-11-01 | Effective date of the Initial Registration Statement and date of the underwriting agreement with Maxim Group LLC. |
| 2024-11-01 | Form 25 filed confirming the suspension of trading for the Companys Common Stock Purchase Warrant. |
| 2024-11-04 | Expiration date of the SurgePays Common Stock Purchase Warrants. |
| 2024-11-12 | Date of the 8-K report filing. |
Keywords
Warrants, Expiration, SurgePays, SURGW, Nasdaq, Maxim Group LLC, Common Stock, Underwriting Agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.